Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Global Prescribed Health apps Market

ID: MRFR/HCIT/18473-HCR
100 Pages
Nidhi Mandole
March 2026

US Prescribed Health Apps Market Research Report By Type (Windows, iPhones, Androids, others), By Devices (Cardiac monitoring device, Diabetes management device, Multi-parameter tracker, Others) and By Application (Individual, Hospitals) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Global Prescribed Health apps Market Infographic
Purchase Options

US Global Prescribed Health apps Market Summary

As per Market Research Future analysis, the US prescribed-health-apps market size was estimated at 118.14 USD Million in 2024. The US global prescribed-health-apps market is projected to grow from 126.26 USD Million in 2025 to 245.41 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US global prescribed-health-apps market is experiencing robust growth driven by technological advancements and regulatory support.

  • The market is witnessing increased regulatory support, which is likely to enhance the adoption of prescribed health apps.
  • Patient empowerment is becoming a focal point, as users seek more control over their health management through digital solutions.
  • Integration of advanced technologies is transforming the landscape, with mobile health applications becoming more sophisticated and user-friendly.
  • Rising demand for remote healthcare solutions and increased focus on preventive healthcare are major drivers propelling market growth.

Market Size & Forecast

2024 Market Size 118.14 (USD Million)
2035 Market Size 245.41 (USD Million)
CAGR (2025 - 2035) 6.87%

Major Players

Apple Inc (US), Samsung Electronics (KR), Cerner Corporation (US), Allscripts Healthcare Solutions (US), Epic Systems Corporation (US), Medtronic (US), Philips Healthcare (NL), IBM Watson Health (US), Omada Health (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

US Global Prescribed Health apps Market Trends

the prescribed-health-apps market is currently experiencing a notable transformation, driven by advancements in technology and an increasing emphasis on personalized healthcare. As healthcare providers and patients alike recognize the potential benefits of mobile applications, the adoption of these tools is becoming more widespread. This shift appears to be influenced by a growing demand for remote monitoring and management of health conditions, which allows for more efficient communication between patients and healthcare professionals. Furthermore, regulatory bodies are beginning to establish frameworks that support the integration of these applications into standard healthcare practices, thereby enhancing their credibility and usability. In addition, the market seems to be evolving towards a more patient-centric approach, where individuals are empowered to take control of their health through the use of prescribed applications. This trend indicates a potential shift in the dynamics of healthcare delivery, as patients increasingly seek tools that facilitate self-management and improve health outcomes. The ongoing development of innovative features, such as artificial intelligence and data analytics, may further enhance the functionality of these applications, making them indispensable in modern healthcare. As the landscape continues to change, stakeholders must remain vigilant to adapt to emerging trends and consumer preferences.

Increased Regulatory Support

Regulatory bodies are establishing guidelines that promote the safe and effective use of prescribed-health-apps. This support is likely to enhance the credibility of these applications, encouraging healthcare providers to integrate them into their practices.

Focus on Patient Empowerment

There is a growing emphasis on empowering patients to manage their health through prescribed applications. This trend suggests a shift towards more personalized healthcare, where individuals actively participate in their treatment plans.

Integration of Advanced Technologies

The incorporation of advanced technologies, such as artificial intelligence and data analytics, is becoming more prevalent in prescribed-health-apps. This integration may improve the functionality and effectiveness of these tools, leading to better health outcomes.

US Global Prescribed Health apps Market Drivers

Increased Focus on Preventive Healthcare

the prescribed-health-apps market is witnessing a growing emphasis on preventive healthcare, which is reshaping the landscape of health management. With healthcare costs in the US escalating, there is a pressing need to shift from reactive to proactive health strategies. Prescribed health apps play a crucial role in this transition by enabling users to monitor their health indicators and receive timely interventions. Data suggests that preventive measures can reduce healthcare expenditures by up to 30%, making these applications an attractive option for both patients and providers. By promoting healthier lifestyles and early detection of potential health issues, these apps contribute to improved health outcomes and reduced healthcare costs. Consequently, the focus on preventive healthcare is likely to propel the growth of the global prescribed-health-apps market in the coming years.

Regulatory Changes Favoring Digital Health

The global prescribed-health-apps market is experiencing a shift due to regulatory changes that favor the adoption of digital health solutions. Recent policy updates in the US have streamlined the approval process for health apps, making it easier for developers to bring their products to market. This regulatory support is crucial, as it encourages innovation and investment in the sector. For example, the FDA has introduced guidelines that facilitate the development of software as a medical device, which directly impacts the global prescribed-health-apps market. As regulations become more favorable, it is anticipated that the number of prescribed health apps will increase, providing patients with a wider array of options for managing their health. This trend may lead to enhanced competition and further advancements in the quality and effectiveness of health applications.

Technological Advancements in Mobile Health

The global prescribed-health-apps market is significantly influenced by rapid technological advancements in mobile health. Innovations such as artificial intelligence, machine learning, and wearable technology are enhancing the functionality and effectiveness of health applications. For instance, AI-driven analytics can provide personalized health insights, while wearables can track vital signs in real-time. The integration of these technologies is expected to increase user engagement and satisfaction, as they offer tailored health solutions. Market data indicates that the mobile health market is projected to reach $200 billion by 2025, underscoring the potential for growth in the global prescribed-health-apps market. As technology continues to evolve, the capabilities of prescribed health apps will likely expand, attracting more users and healthcare providers alike.

Rising Demand for Remote Healthcare Solutions

The global prescribed-health-apps market is experiencing a notable surge in demand for remote healthcare solutions. This trend is largely driven by the increasing prevalence of chronic diseases in the US, which necessitates continuous monitoring and management. According to recent data, approximately 60% of adults in the US live with at least one chronic condition, creating a substantial need for effective health management tools. Prescribed health apps offer patients the ability to track their health metrics, communicate with healthcare providers, and receive personalized care plans. This shift towards remote healthcare not only enhances patient engagement but also reduces the burden on healthcare facilities, thereby driving growth in the global prescribed-health-apps market. As more patients seek convenient and accessible healthcare options, the demand for these applications is expected to rise significantly.

Growing Acceptance of Digital Health Solutions

The global prescribed-health-apps market is benefiting from the increasing acceptance of digital health solutions among both patients and healthcare professionals. As the healthcare landscape evolves, there is a growing recognition of the value that technology brings to health management. Surveys indicate that over 70% of healthcare providers in the US are now utilizing some form of digital health technology, which includes prescribed health apps. This acceptance is driven by the desire for improved patient outcomes and streamlined healthcare processes. Furthermore, as patients become more tech-savvy, their willingness to adopt digital health solutions is also rising. This trend is likely to foster a more favorable environment for the global prescribed-health-apps market, as both patients and providers seek innovative ways to enhance health management.

Market Segment Insights

By Type: iPhones (Largest) vs. Androids (Fastest-Growing)

In the US global prescribed-health-apps market, iPhones dominate the type segment with a significant market share, showcasing their strong user base and brand loyalty. Meanwhile, Androids are gaining traction, appealing to a broader audience due to their diverse range of devices and price options, thus capturing a noteworthy portion of the market share. The competitive landscape highlights that, while iPhones maintain their supremacy, Androids are rapidly evolving and expanding their customer reach. The growth trends within this segment are driven by increasing smartphone adoption rates and the surge in health-conscious consumers actively seeking health solutions through apps. Moreover, the enhancement of app functionalities, personalization options, and integration with wearable technologies have bolstered the appeal of Androids, which are expected to show rapid growth in user adoption in the coming years. iPhones, however, continue to lead in quality-related user retention, ensuring their position in the market remains stable despite competitive pressures.

iPhones (Dominant) vs. Androids (Emerging)

The iPhones segment is characterized by its robust ecosystem, offering a seamless user experience which fosters customer loyalty and retention. The premium quality of apps available on this platform attracts health-conscious consumers who value reliability and security in their healthcare management tools. On the other hand, the Androids segment represents an emerging market with diverse offerings catering to different demographics and preferences. The flexibility of the Android platform allows for innovative and cost-effective solutions, appealing to a wide audience. As health applications continue to evolve, both segments are poised for unique growth trajectories, but iPhones maintain a dominant presence owing to their established reputation and high-quality app offerings.

By Device: Cardiac Monitoring Device (Largest) vs. Multi-parameter Tracker (Fastest-Growing)

In the US global prescribed-health-apps market, the cardiac monitoring device segment holds the largest share, driven by an increasing prevalence of cardiovascular diseases and a growing aging population. The diabetes management device and multi-parameter tracker segments are also significant contributors, each catering to specific health monitoring needs, but they lag behind cardiac monitoring in terms of market dominance. Growth trends in this segment indicate a rising demand for advanced health tracking technologies, particularly among chronic disease patients. The integration of AI and remote monitoring features is capturing consumer interest, leading to a surge in adoption rates for multi-parameter trackers, which are quickly emerging as a crucial tool for comprehensive health management, thus making them the fastest-growing segment.

Cardiac Monitoring Device (Dominant) vs. Multi-parameter Tracker (Emerging)

The cardiac monitoring device segment is established as the dominant player in the US global prescribed-health-apps market, primarily due to its critical role in the ongoing management of heart conditions. These devices provide real-time data, empowering users to take immediate actions based on their heart health. Meanwhile, the multi-parameter tracker serves as an emerging competitor by offering versatile health monitoring capabilities that range across various metrics including heart rate, sleep patterns, and activity levels. It is particularly appealing to health-conscious consumers and those seeking preventative care, thus gaining traction in the consumer base and establishing itself as a vital tool in holistic healthcare.

By Applications: Individual (Largest) vs. Hospitals (Fastest-Growing)

In the US global prescribed-health-apps market, the application segment is primarily dominated by the Individual category, which commands a significant market share. This sector thrives due to the increasing personalization of healthcare solutions that enable users to manage their health. Meanwhile, the Hospitals segment is rapidly gaining traction, expanding its share as more healthcare facilities adopt advanced digital solutions to enhance patient care and operational efficiency. The growth trends for these segments reflect a shift towards digital health engagement among individuals as well as a surge in hospitals adopting prescribed-health applications. Factors such as the rise in chronic diseases, the need for improved patient monitoring, and a growing emphasis on telehealth services are driving this growth. Consequently, the Hospitals segment is expected to continue its upward trajectory, becoming a key player in the overall market space.

Applications: Individual (Dominant) vs. Hospitals (Emerging)

The Individual application segment in the US global prescribed-health-apps market is characterized by its strong user engagement and a wide array of health management tools that cater to personal health needs. These applications provide users with tailored health solutions, such as medication reminders, fitness tracking, and mental health support, resulting in high adoption rates among consumers. In contrast, the Hospitals segment, while still emerging, is witnessing rapid adoption as healthcare institutions recognize the benefits of integrating technology into patient care. Hospitals are increasingly turning to these applications for better data management, patient engagement, and streamlined health service delivery, indicating a promising growth trajectory that could challenge the dominance of Individual applications in the coming years.

Get more detailed insights about US Global Prescribed Health apps Market

Key Players and Competitive Insights

The global prescribed-health-apps market is currently characterized by a dynamic competitive landscape, driven by rapid technological advancements and an increasing emphasis on patient-centric care. Key players such as Apple Inc (US), Cerner Corporation (US), and Omada Health (US) are strategically positioning themselves through innovation and partnerships. Apple Inc (US) has been focusing on integrating health monitoring features into its devices, enhancing user engagement and data collection capabilities. Cerner Corporation (US) is leveraging its extensive healthcare data analytics to improve patient outcomes, while Omada Health (US) is emphasizing personalized health solutions through digital interventions. Collectively, these strategies are shaping a competitive environment that prioritizes technological integration and patient engagement.In terms of business tactics, companies are increasingly localizing their operations and optimizing supply chains to enhance efficiency and responsiveness. The market appears moderately fragmented, with a mix of established players and emerging startups. This structure allows for diverse offerings, yet the influence of key players remains substantial, as they set benchmarks for innovation and service delivery.

In October Apple Inc (US) announced a partnership with a leading health insurance provider to integrate its health app features into their services. This strategic move is likely to enhance user accessibility and broaden the app's reach, potentially increasing user adoption rates. By aligning with insurance providers, Apple Inc (US) appears to be reinforcing its commitment to health management and preventive care, which could lead to improved health outcomes for users.

In September Cerner Corporation (US) launched a new AI-driven analytics platform aimed at streamlining patient data management for healthcare providers. This initiative is significant as it not only enhances operational efficiency but also positions Cerner Corporation (US) as a leader in the integration of AI within healthcare applications. The platform's capabilities may facilitate better decision-making processes for healthcare professionals, thereby improving patient care.

In August Omada Health (US) expanded its digital health platform to include new behavioral health modules, addressing a growing need for mental health support. This expansion is indicative of a broader trend towards holistic health solutions, where companies are recognizing the importance of mental well-being alongside physical health. By diversifying its offerings, Omada Health (US) is likely to attract a wider user base and enhance its competitive edge.

As of November the most pressing trends in the global prescribed-health-apps market include the increasing digitalization of healthcare, a focus on sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies seek to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition towards innovation, technological advancements, and supply chain reliability. This transition suggests that companies that prioritize these aspects will likely gain a competitive advantage in the increasingly complex healthcare landscape.

Key Companies in the US Global Prescribed Health apps Market include

Industry Developments

In recent months, the US Prescribed Health Apps Market has witnessed significant growth and activity.WellDoc has actively expanded its offerings, focusing on chronic disease management through digital platforms, while Hims and Hers Health continues to innovate in telehealth, particularly in mental health services. Epic Systems and Teladoc Health have been improving their digital health services, aiming to enhance patient experience.

In October 2023, UnitedHealth Group announced an acquisition of a health tech startup, further solidifying its position in the market. Johnson and Johnson's digital ventures are also on the rise, notably enhancing their health app capabilities for better patient monitoring. Zebra Medical Vision made strides in imaging analytics, which impacts clinical decision-making.

Furthermore, Medtronic has been focusing on chronic disease management through advanced apps, while Apple and Samsung are continually integrating health functionalities into their devices. Notably, the market has seen increased investments aimed at improving healthcare access and management, responding to the growing demand for telehealth solutions following the pandemic.

Over the past few years, significant advancements have been made in regulatory approval pathways, further facilitating innovation in prescribed health applications.

Future Outlook

US Global Prescribed Health apps Market Future Outlook

The prescribed-health-apps market is projected to grow at a 6.87% CAGR from 2025 to 2035, driven by technological advancements, increasing health awareness, and regulatory support.

New opportunities lie in:

  • Integration of AI-driven analytics for personalized health insights.
  • Development of subscription-based models for continuous patient engagement.
  • Partnerships with healthcare providers for integrated care solutions.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare dynamics.

Market Segmentation

US Global Prescribed Health apps Market Type Outlook

  • Windows
  • iPhones
  • Androids
  • Others

US Global Prescribed Health apps Market Device Outlook

  • Cardiac monitoring device
  • Diabetes management device
  • Multi-parameter tracker
  • Others

US Global Prescribed Health apps Market Applications Outlook

  • Individual
  • Hospitals

Report Scope

MARKET SIZE 2024 118.14(USD Million)
MARKET SIZE 2025 126.26(USD Million)
MARKET SIZE 2035 245.41(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.87% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Apple Inc (US), Samsung Electronics (KR), Cerner Corporation (US), Allscripts Healthcare Solutions (US), Epic Systems Corporation (US), Medtronic (US), Philips Healthcare (NL), IBM Watson Health (US), Omada Health (US)
Segments Covered Type, Device, Applications
Key Market Opportunities Integration of artificial intelligence for personalized patient care in the global prescribed-health-apps market.
Key Market Dynamics Rising regulatory scrutiny and technological advancements drive innovation in the global prescribed-health-apps market.
Countries Covered US
Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Garvit Vyas LinkedIn
Vice President - Operations
Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.
Leave a Comment

FAQs

What was the market valuation of the US global prescribed-health-apps market in 2024?

The market valuation was $118.14 Million in 2024.

What is the projected market valuation for the US global prescribed-health-apps market by 2035?

The projected valuation for 2035 is $245.41 Million.

What is the expected CAGR for the US global prescribed-health-apps market during the forecast period 2025 - 2035?

The expected CAGR is 6.87% during the forecast period 2025 - 2035.

Which companies are considered key players in the US global prescribed-health-apps market?

Key players include Apple Inc, Samsung Electronics, Cerner Corporation, Allscripts Healthcare Solutions, Epic Systems Corporation, Medtronic, Philips Healthcare, IBM Watson Health, and Omada Health.

What are the main segments of the US global prescribed-health-apps market by type?

The main segments by type include Windows, iPhones, Androids, and Others.

What were the valuations for iPhones in the US global prescribed-health-apps market in 2024?

The valuations for iPhones were between $40.0 Million and $80.0 Million in 2024.

What devices are included in the US global prescribed-health-apps market?

Devices include cardiac monitoring devices, diabetes management devices, multi-parameter trackers, and others.

What was the valuation range for diabetes management devices in 2024?

The valuation range for diabetes management devices was between $30.0 Million and $60.0 Million in 2024.

What applications are considered in the US global prescribed-health-apps market?

Applications include individual users and hospitals.

What was the valuation for individual applications in the US global prescribed-health-apps market in 2024?

The valuation for individual applications was between $70.0 Million and $150.0 Million in 2024.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions